Ian Muir has 30 years’ experience in the pharmaceutical industry. With a PhD in Pharmaceutical Science, he has worked for GSK, Wyeth and Mayne Pharma in the UK, US and Australia. He then moved to the CDMO sector joining Catalent Pharma Services the global CDMO, where he held both technical and commercial roles, ultimately leading their global oral products division. He has experience operating as CEO at both Aesica Pharma and Famar. Most recently he has been a principal advisor at Results Healthcare in their M&A team and the lead for the contract manufacture team of the UK BEiS, Vaccine Task Force.